Best Private Grants for Nonprofits in American Samoa

The NIDDK Multi-Purpose Resource-Related Research Centers Cooperative Agreement (U2C) invites applications to enhance research capabilities in areas such as obesity and diabetes. These centers provide specialized services, including technical support and data coordination, primarily to clients at other institutions lacking necessary expertise. This initiative aims to bolster high-impact research through collaboration and experiential training, addressing critical health challenges aligned with NIDDK's mission.

The KUH U24 Center Coordinating Hub aims to foster collaboration among funded Centers within the NIDDK/KUHN mission. This initiative encourages the development and sharing of vital research resources, including data, reagents, and expertise, with the broader scientific community. By creating a national network, the program enhances research capabilities and promotes innovative solutions in kidney, urology, and hematology diseases.

The KUH P30 Resource Core Center funding opportunity invites applications for centers aimed at enhancing research in Kidney, Urology, and Hematology diseases. These centers will provide essential resources, including data and tools, to the research community, fostering collaboration through a national network with the Center Coordinating Hub. This initiative by the National Institutes of Health aims to drive innovative research and shared expertise for improved health outcomes.

The Women's Initiative for Screening and Health (WISH) aims to enhance women's health by improving access to preventive services. It focuses on updating HRSA-supported guidelines, increasing awareness of these guidelines, and promoting their adoption in clinical practice. By collaborating with healthcare providers, academic institutions, and patient organizations, WISH strives to implement a comprehensive strategy that benefits women's health across their lifespan.

Jazz Road Tours Grants provide financial support for emerging and mid-career jazz artists to develop tours across communities in the U.S. Grants up to $15,000 facilitate three-to-six site tours, focusing on underserved areas. This program, funded by the Doris Duke Charitable Foundation and the Mellon Foundation, aims to enhance artists' income opportunities while promoting jazz in diverse venues. Applications are encouraged from individual artists, with deadlines throughout 2024 and 2025 for various tour periods.

The TourWest Grants, funded by the National Endowment for the Arts, aim to support presenters and organizations in the Western region by providing flexible funding for touring artists. This competitive grant encourages community engagement and outreach, fostering collaboration between artists and local communities. It prioritizes accessibility to the performing arts, especially in underserved areas. Applicants must be tax-exempt organizations or local government units and demonstrate a commitment to community needs through their projects.

The FY26 Autism Research Program Career Development Award aims to support early-career investigators in conducting innovative research that can significantly impact autism. It encourages applications addressing specific areas of interest and mandates community collaboration for projects involving pilot clinical trials. Proposals must include partnerships with community members for effective planning and implementation, ensuring that the research is grounded in the needs of the autism community.

The FR Vietnam program, initiated by USDA/FAS in 2023, aims to improve fertilizer efficiency and effectiveness while reducing reliance on traditional chemical fertilizers. By collaborating with the Ministry of Agriculture and Environment, the program focuses on innovative biofertilizers and enhanced efficiency fertilizers. Key activities include comparative analyses, outreach tours featuring U.S. organic rice farmers, and developing national guidelines for sustainable fertilizer management. These efforts support sustainable agriculture and enhance the import of U.S. biofertilizer products in Vietnam.

The Changemakers in Family Planning Grant Program aims to address institutionalized racism in the field of family planning by providing essential support to scholars of color. Recognizing that diversity and equity are crucial for advancing research in abortion and contraception, this initiative seeks to foster an inclusive community that empowers underrepresented voices in science. The Society of Family Planning is dedicated to creating a just environment where all scholars can contribute to meaningful advancements in family planning research.

The FY26 Peer Reviewed Medical Research Program Clinical Trial Award promotes the swift initiation of impactful clinical trials for diseases outlined in specific topic areas. It offers two application categories: Clinical Trial Only and Clinical Trial with Planning Phase, supporting various funding levels based on trial phases and participant counts. The total funding of approximately $94.5M aims to support up to 9 applications, with a maximum award period of 4 years, ensuring significant advancements in medical research.

The FY26 Bone Marrow Failure Research Program's Resource Development Award aims to create a multiomic atlas from human bone marrow failure samples. This resource will be open-access, providing essential data for researchers and clinicians to enhance their understanding of bone marrow failure diseases. A comprehensive Data Resource Sharing Plan is required to ensure timely availability of the developed resource, fostering collaboration within the scientific community.

The Lung Cancer Patient-Centered Outcomes and Survivorship Award (PCOSA) aims to enhance health outcomes for lung cancer patients by promoting patient-centered research. This FY26 initiative encourages projects that address key areas of survivorship and requires the involvement of lung cancer survivors or caregivers in research teams. Additionally, it supports both translational and clinical research, including pilot clinical trials, to improve the overall patient experience.

The FY26 Duchenne Muscular Dystrophy Research Program's Clinical/Translational Research Award supports pivotal research aimed at translating innovative therapeutic strategies into clinical applications for Duchenne muscular dystrophy (DMD). Two funding levels cater to diverse project complexities, along with a Partnering PI Option promoting collaboration between early-career and established investigators. This initiative emphasizes the integration of preliminary data and encourages pilot trials to advance DMD therapies effectively.

The FY26 Duchenne Muscular Dystrophy Research Program's Idea Development Award promotes innovative, high-risk research aimed at advancing treatment for Duchenne muscular dystrophy (DMD). It encourages projects with a strong scientific basis and feasibility, focusing on therapies that work across all ages, including infants and nonambulatory patients. Eligible applicants include experienced and transitioning investigators, fostering diverse expertise to enhance DMD research and improve patient outcomes.

The DoW Bone Marrow Failure Investigator-Initiated Research Award supports innovative research aimed at advancing the understanding and treatment of bone marrow failure. This funding opportunity encourages applications for translational and clinical studies, requiring preliminary data to strengthen proposals. Unique features include the ability for a partnering Principal Investigator to contribute to the research, thereby fostering collaboration while maintaining a focus on significant advancements in patient care.

The DoW Bone Marrow Failure Idea Development Award supports innovative, high-impact research aimed at understanding and curing bone marrow failure diseases. This grant is available to both Established Investigators and Early-Career Investigators, with no preliminary data required for applications. Reviewers assess proposals based on specific criteria tailored to the investigator's career stage. The focus is on achieving interpretable results that contribute significantly to the field.

The Lung Cancer Translational Research Award (TRA) for FY26 supports innovative translational research aimed at transforming promising lung cancer ideas into clinical applications. This award emphasizes advanced preclinical studies and pilot clinical trials of novel interventions, addressing critical research areas within the Lung Cancer Research Program. Applicants can choose between two funding levels to advance their impactful studies, thereby contributing to significant advancements in lung cancer treatment.

The FY26 Military Burn Research Program (MBRP) Technology/Therapeutic Development Award (TTDA) aims to translate promising preclinical findings into burn products for clinical use in challenging environments. This award supports the development of both tangible products, like medical devices, and knowledge products that enhance health outcomes. A new Mentorship Option encourages collaboration between experienced researchers and junior scientists, fostering the next generation of leaders in military burn care research.

The FY26 Military Burn Research Program (MBRP) Discovery Award aims to support groundbreaking research in combat-relevant burn care. This award encourages innovative and exploratory studies that provide new insights and foundational data for future clinical research. The focus is on novel approaches that lay the groundwork for scientific advancements and product development in burn care, ensuring robust preliminary data generation for subsequent research initiatives.

The Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) program is designed to enhance research on muscular dystrophy through a collaborative, center-based approach. By fostering interdisciplinary projects and providing essential training for emerging scientists, the MDSRCs aim to drive innovation in both basic and clinical research. Engaging patient and advocacy communities is a key component, ensuring research is patient-centered and informed by real-world needs. This initiative is supported by various legislative authorities.

This initiative aims to support research interventions targeting disparities in liver diseases and liver cancer among underserved populations in the U.S. It encourages innovative approaches to reduce health inequities and improve health outcomes. The funding opportunity is available through various deadlines for both standard and renewal applications, promoting multi-level strategies to address these critical health issues effectively.

The National Institutes of Health is funding a groundbreaking project to enhance our understanding of Type 1 diabetes (T1D) through multimodal AI. This initiative aims to integrate diverse datasets to explore the interactions of biological processes in T1D development. By leveraging advanced AI models, the research will uncover critical insights, identify biomarkers, and pave the way for personalized medicine approaches, ultimately improving prevention and treatment strategies for this complex disease.

The NIMH Career Transition Award (K22) supports tenure-track intramural investigators at NIMH in their transition to independent research faculty positions. This program aims to foster innovative research in mental health, encouraging applicants with a strong record of research excellence. Key deadlines for applications vary, including those for standard and renewal submissions, emphasizing the importance of timely applications to secure funding and advance mental health research initiatives.

The DoW Military Burn, Patient-Centered Research Award aims to enhance the implementation of burn care research into clinical practice for military settings. The FY26 program supports clinical trials and research that directly benefit burn patients in resource-limited environments, fostering collaborations between experienced researchers and junior scholars. This initiative addresses critical gaps in combat burn care, ensuring effective interventions and guidelines are developed and utilized in operational battlespaces.

The DoW Prostate Cancer Idea Development Award for fiscal year 2026 supports innovative research ideas that address the Prostate Cancer Research Program's overarching challenges. This award emphasizes new investigators within 10 years of their terminal degree, encouraging collaboration with experienced researchers in the field. By fostering unique approaches to prostate cancer research, the program aims to make significant contributions to advancing understanding and treatment of this disease.

The FY26 Prostate Cancer Research Program (PCRP) Early Investigator Research Award supports early-career researchers focusing on prostate cancer. Eligible applicants must possess a doctoral degree and less than three years of postdoctoral experience. Each application requires a mentorship component, ensuring guidance from an experienced researcher, along with a detailed development plan outlining the skills and expertise necessary for project completion and career advancement. This award addresses critical challenges in prostate cancer research.

The FY26 Prostate Cancer Research Program (PCRP) Physician Research Award supports early-career clinician investigators in their transition to prostate cancer research. Applicants must include a mentor with relevant experience and outline a personalized development plan aimed at acquiring essential research skills. The award encourages innovative approaches to addressing the program's overarching challenges, ultimately enhancing the career trajectories of participating physicians in this critical field.